101
Views
8
CrossRef citations to date
0
Altmetric
Research Article

INSIGHT INTO SOME OF THE SIGNALING PATHWAYS TRIGGERED BY A LIPID IMMUNOMODULATOR

, , , , &
Pages 527-546 | Published online: 12 Feb 2002
 

ABSTRACT

The use of non specific immunomodulatory agents takes an important place in the aspecific host response to invading microorganisms. In this context, antimicrobial properties of royal jelly have been ascribed to organic acids (mainly 10 hydroxy-2-decenoic acid or 10-HDA) and proteins. We synthesized a derivative of 10-HDA, the 1-(2-methoxy-ethoxymethyl)2,3-(10-hydroxy2-decenoyl)(E) glycerol referred as diHDA-glycerol which was previously found to protect mice against virulent Salmonella typhimurium challenge through more adequate immune regulations. This study was conducted to further investigate some of the signaling pathways followed by diHDA-glycerol in cell transduction. Members of NF-κB transcription factors are key regulators of many cytokines acting on immunity and they control genes involved in responses to numerous signals such as bacterial products. Therefore, we investigated some parameters acting on NF-κB translocation in U937 cells after diHDA-glycerol treatment. Due to the chemical structure of the molecule we also investigated the sphingomyelinase pathway. Our results showed that diHDA-glycerol induced a rapid NF-κB translocation as a consequence of IκB-α proteolysis. An intracellular production of reactive oxygen species (ROS) may also account for NF-κB activation, without de novo protein synthesis. DiHDA-glycerol induced a strong activation of neutral sphingomyelinase, suggesting an important role of sphingolipids in the regulatory responses induced by diHDA-glycerol.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.